Latest Financial Performance News

Civmec Limited reports a 24.3% drop in revenue and a 19% fall in net profit for the half year ended December 2025, while advancing its naval shipbuilding footprint through the acquisition of Luerssen Australia.

GQG Partners delivered solid full-year 2025 results, with funds under management climbing 7.1% to US$163.9 billion and net income increasing 7.3% to US$463.3 million, despite net outflows. The firm maintained a strong dividend payout, reflecting confidence in its sustainable growth strategy.

Webjet Group has ended acquisition discussions with Helloworld and BGH Capital, reaffirming its focus on executing its FY30 growth strategy while confirming FY26 EBITDA guidance and a $25 million share buy-back.

BWP Group has reported a robust 41.2% increase in statutory profit for the half-year ending December 2025, alongside a 4.1% rise in interim distributions and a growing portfolio valued at $3.9 billion.

BWP Group has reported a 3% rise in revenue to $103.6 million for the half-year ending December 2025, driven by rental growth and strategic acquisitions. The internalisation of management has reduced fees and positioned the group for future growth.

GQG Partners Inc. reported a 6.3% increase in net revenue and a 7.3% rise in net profit for 2025, alongside a strategic US ETF launch and a new dividend declaration.

Cochlear Limited has announced an ordinary dividend of AUD 2.15 per share for the six months ending December 2025, with payments scheduled for April 2026 and options for currency conversion based on shareholder location.

Westpac Banking Corporation reported a 6% rise in net profit for the first quarter of 2026, underpinned by strong capital ratios and ongoing transformation initiatives. The bank’s strategic focus on customer service and operational efficiency signals a confident outlook amid evolving market conditions.

Northern Star Resources has reported a robust half-year result with a 41% jump in net profit, driven by soaring gold prices despite operational setbacks. The company also announced a fully franked interim dividend of 25 cents per share.

Invex Therapeutics reports a net loss of $715,582 for H1 2026 while advancing its Exenatide program targeting neurological diseases, alongside notable board reshuffles.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

ASX Limited reported robust first-half results with 11.2% revenue growth, while advancing a strategic reset in response to the ASIC Inquiry and pushing forward its technology modernization agenda.